Argentina · Delayed Price · Currency is ARS AbbVie Statistics
Total Valuation
AbbVie has a market cap or net worth of ARS 557.47 trillion. The enterprise value is 650.33 trillion.
| Market Cap | 557.47T |
| Enterprise Value | 650.33T |
Important Dates
The last earnings date was Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | Oct 15, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 73.83% |
| Float | 1.76B |
Valuation Ratios
The trailing PE ratio is 173.24 and the forward PE ratio is 16.06.
| PE Ratio | 173.24 |
| Forward PE | 16.06 |
| PS Ratio | 6.82 |
| PB Ratio | -2,947.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 202.10 |
| EV / Sales | 7.53 |
| EV / EBITDA | 15.28 |
| EV / EBIT | 21.60 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.40 |
| Debt / FCF | n/a |
| Interest Coverage | 6.44 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 17.59% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.49B |
| Profits Per Employee | 58.51M |
| Employee Count | 55,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1,007.32B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +41.05% |
| 50-Day Moving Average | 32,738.60 |
| 200-Day Moving Average | 25,824.28 |
| Relative Strength Index (RSI) | 45.73 |
| Average Volume (20 Days) | 948 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AbbVie had revenue of ARS 81.74 trillion and earned 3.22 trillion in profits. Earnings per share was 1,809.89.
| Revenue | 81.74T |
| Gross Profit | 57.30T |
| Operating Income | 28.51T |
| Pretax Income | 2.28T |
| Net Income | 3.22T |
| EBITDA | 39.82T |
| EBIT | 28.51T |
| Earnings Per Share (EPS) | 1,809.89 |
Balance Sheet
The company has 8.86 trillion in cash and 96.74 trillion in debt, giving a net cash position of -87,873.72 billion.
| Cash & Cash Equivalents | 8.86T |
| Total Debt | 96.74T |
| Net Cash | -87,873.72B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -189.13B |
| Book Value Per Share | -141.98 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.10%, with operating and profit margins of 34.88% and 4.00%.
| Gross Margin | 70.10% |
| Operating Margin | 34.88% |
| Pretax Margin | 2.78% |
| Profit Margin | 4.00% |
| EBITDA Margin | 48.72% |
| EBIT Margin | 34.88% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 584.54, which amounts to a dividend yield of 1.78%.
| Dividend Per Share | 584.54 |
| Dividend Yield | 1.78% |
| Dividend Growth (YoY) | 66.60% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.78% |
| Earnings Yield | 0.58% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |